戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ve with history of pacemaker insertion had a multivariable-adjusted 1.68-fold (incidence rate ratio,
2 ized aortic size in the upper quartile had a multivariable-adjusted ~3-fold increased odds ratio of b
3 s the lowest quartile of PVC frequency had a multivariable-adjusted, 3-fold greater odds of a 5-year
4 ed with lower relative cMGP concentration in multivariable adjusted analyses (beta=-8.99; P=0.04).
5                                           In multivariable adjusted analyses, kidney disease associat
6                                           In multivariable adjusted analyses, there was no significan
7 in 2005/2007; 2.7% in 2009/2011; P=0.19) and multivariable adjusted analyses.
8                                           In multivariable-adjusted analyses (n = 5,708), higher long
9                                           In multivariable-adjusted analyses considering joint effect
10     Risk factors for asthma were examined by multivariable-adjusted analyses done in all participants
11 y associated with increased risk of death in multivariable-adjusted analyses of time-varying FGF23 (h
12 /MS- had 2.5% lower LS (SE, 0.7%; P=0.001 in multivariable-adjusted analyses) and 10.8 ms greater dys
13                                           In multivariable-adjusted analyses, a moderate-to-severe re
14                              In time-updated multivariable-adjusted analyses, compared with those wit
15 FA," and "high medium-chain fatty acids." In multivariable-adjusted analyses, fish oil supplementatio
16                                           In multivariable-adjusted analyses, lower risk of becoming
17                                           In multivariable-adjusted analyses, triglycerides (hazard r
18                                        Valid multivariable-adjusted analysis can be performed in dist
19                                    In pooled multivariable-adjusted analysis, both PDI and hPDI were
20                                           In multivariable-adjusted analysis, factors associated with
21                                In the pooled multivariable-adjusted analysis, participants who consum
22                                         In a multivariable-adjusted analysis, the Crs was independent
23 sponding OR estimates from the conventional, multivariable adjusted, and Egger Mendelian randomisatio
24              We evaluated the unadjusted and multivariable-adjusted association between pretransplant
25                   On a continuous scale, the multivariable-adjusted association of potassium values a
26                                          The multivariable-adjusted association of serum potassium wi
27                                 We evaluated multivariable-adjusted associations with IOP using linea
28                                              Multivariable-adjusted competing risk analysis examined
29                                              Multivariable-adjusted competing risk survival models we
30                                           In multivariable-adjusted conditional logistic regression a
31 ths of each biomarker was estimated by using multivariable-adjusted conditional logistic regression i
32                                        Using multivariable-adjusted conditional logistic regression m
33                                           In multivariable-adjusted conditional logistic regression m
34  intake with HCC risk was evaluated by using multivariable-adjusted conditional logistic regression t
35  concentration) and LC were calculated using multivariable-adjusted conditional logistic regression.
36 tion) and liver cancer were calculated using multivariable-adjusted conditional logistic regression.
37                  In stepwise regression, the multivariable-adjusted correlates of the change in the t
38 ection fraction <45%) were assessed by using multivariable adjusted Cox models and restricted cubic s
39                                              Multivariable adjusted Cox models with non-HDL cholester
40 rameters with risk of HF were evaluated with multivariable adjusted Cox models.
41                                              Multivariable adjusted Cox proportional hazards models w
42                                              Multivariable adjusted Cox proportional hazards models w
43      Hazard ratios (HRs) were estimated with multivariable adjusted Cox proportional hazards models,
44  95% confidence intervals were obtained from multivariable adjusted Cox proportional hazards regressi
45                                              Multivariable adjusted Cox regression was used to examin
46                                      We used multivariable-adjusted Cox hazards models to evaluate th
47 iated with a lower risk of hip fracture in a multivariable-adjusted Cox model (hazard ratio, 0.35; 95
48 t CHD and stroke events were evaluated using multivariable-adjusted Cox models and multiplicative int
49  disease, and incident ischemic stroke using multivariable-adjusted Cox models in a nationwide cohort
50                                              Multivariable-adjusted Cox models tested the association
51                                            A multivariable-adjusted Cox proportional hazard model was
52                               Sex-stratified multivariable-adjusted Cox proportional hazards modeling
53                                              Multivariable-adjusted Cox proportional hazards models w
54                         Using sex-stratified multivariable-adjusted Cox proportional hazards models,
55                                           In multivariable-adjusted Cox proportional hazards models,
56  and for death due to prostate cancer, using multivariable-adjusted Cox proportional hazards models.
57 for an enlarged segment was determined using multivariable-adjusted Cox proportional hazards models.
58 1:5 propensity score-matched and traditional multivariable-adjusted Cox proportional hazards models.
59 t letter acuity in discovery (n = 582) using multivariable-adjusted Cox proportional hazards models.
60 llow-up Study and Nurses' Health Study using multivariable-adjusted Cox proportional hazards regressi
61                                              Multivariable-adjusted Cox proportional-hazards models w
62                                           In multivariable-adjusted Cox regression analyses, ID assoc
63 e mortality was assessed using time-updated, multivariable-adjusted Cox regression analyses.
64  CI, 1.10 to 3.20; P = .021) and traditional multivariable-adjusted Cox regression analysis (hazard r
65                                              Multivariable-adjusted Cox regression models estimated h
66 d all-cause mortality were assessed by using multivariable-adjusted Cox regression models.
67  and all-cause mortality using time-updated, multivariable-adjusted Cox regression.
68                                          The multivariable-adjusted decline in FEV1 in asthma-COPD ov
69                                          The multivariable-adjusted differences in 5-year cumulative
70                                              Multivariable-adjusted differences in standardized cogni
71                                          The multivariable-adjusted effect estimates were pooled by r
72                                         In a multivariable-adjusted estimates, left atrium volume >16
73                                              Multivariable-adjusted fixed-effect regression models fo
74 tion in major adverse cardiovascular events (multivariable adjusted hazard ratio [HR(adj)]=0.75, 95%
75                                            A multivariable adjusted hazard ratio of mortality for SxO
76 ardiovascular disease, the authors estimated multivariable adjusted hazard ratios (HR) for MI (5,128
77                          Survival curves and multivariable adjusted hazard ratios (HRs) were used to
78                                          The multivariable adjusted hazard ratios and 95% confidence
79  compared with never-smokers without asthma, multivariable adjusted hazard ratios for asthma exacerba
80                                We calculated multivariable adjusted hazard ratios for midwall, endoca
81 uals without COPD, those with early COPD had multivariable adjusted hazard ratios of 6.42 (95% confid
82 he Copenhagen General Population Study, with multivariable adjusted hazard ratios up to 1.99 (95%conf
83  For the highest quartile versus lowest, the multivariable-adjusted hazard rate ratios were 0.91 (95%
84                                          The multivariable-adjusted hazard ratio (HR) (95% confidence
85  g had a 32% greater risk for breast cancer (multivariable-adjusted hazard ratio (HR) = 1.32, 95% con
86 isk of rosacea associated with past smoking (multivariable-adjusted hazard ratio = 1.09, 95% confiden
87 than non-Hispanic white (NHW) patients (NHB: multivariable-adjusted hazard ratio [aHR] 2.57; 95% conf
88 ncident HF with preserved ejection fraction (multivariable-adjusted hazard ratio [HR], 2.34; 95% conf
89 ared with the low genetic risk category, the multivariable-adjusted hazard ratio for coronary heart d
90                 In prospective analyses, the multivariable-adjusted hazard ratio for incident diabete
91  (<18 nmol/l: first to 50th percentile), the multivariable-adjusted hazard ratio for ischemic stroke
92 eat, men who consumed 75 g/day or more had a multivariable-adjusted hazard ratio of 1.21 (95% confide
93 ence interval) was 0.80 (0.76, 0.83) and the multivariable-adjusted hazard ratio was 0.87 (0.83, 0.91
94 ype with kidney allograft failure and death (multivariable-adjusted hazard ratio, (95%LCL) aHR(95%UCL
95 69%, and 71% without secondary precipitants; multivariable-adjusted hazard ratio, 0.65 [95% confidenc
96 diovascular events than those who continued (multivariable-adjusted hazard ratio, 1.37; 95% confidenc
97 sence; difference, 2.92 [95% CI, 2.02-3.83]; multivariable-adjusted hazard ratio, 2.04 [95% CI, 1.44-
98 ncreased hazard of future CV or death event (multivariable-adjusted hazard ratio: 2.03; 95% confidenc
99 ared with being adherent to all 3 therapies, multivariable-adjusted hazard ratios (95% confidence int
100 , and history of cardiovascular disease, the multivariable-adjusted hazard ratios (95% confidence int
101 rds regression modeling was used to estimate multivariable-adjusted hazard ratios (HRs) and 95% CIs.
102 ional hazard regression was used to estimate multivariable-adjusted hazard ratios (HRs) and 95% confi
103 atient survival improved: the unadjusted and multivariable-adjusted hazard ratios (HRs) for death in
104 alysis of the 45 and Up Study calculated the multivariable-adjusted hazard ratios (HRs) of sitting fo
105 ing with time-varying covariates to estimate multivariable-adjusted hazard ratios (MV-adjusted HRs).
106                                              Multivariable-adjusted hazard ratios (MVHRs) and 95% CIs
107 ortional hazards models to estimate age- and multivariable-adjusted hazard ratios and 95% confidence
108                                              Multivariable-adjusted hazard ratios and 95% confidence
109                                              Multivariable-adjusted hazard ratios and 95% confidence
110                       Sex- and race-specific multivariable-adjusted hazard ratios and 95% confidence
111                        [table: see text] The multivariable-adjusted hazard ratios for all-cause morta
112                                          The multivariable-adjusted hazard ratios for death were 1.47
113                                          The multivariable-adjusted hazard ratios for death within 30
114                  Per 1-mmol/l higher levels, multivariable-adjusted hazard ratios for myocardial infa
115 cation pooled-cohort equations), we compared multivariable-adjusted hazard ratios for the composite o
116 g a "standard drink" as 12 g of ethanol, the multivariable-adjusted hazard ratios were 0.77 (95% conf
117 lanoma than with risk of SCC and BCC in men (multivariable-adjusted hazard ratios were 2.41 (95% conf
118                                              Multivariable-adjusted hazard ratios were estimated usin
119  associations with increased mortality risk: multivariable-adjusted HR (95% CI) in the highest compar
120 d inverse associations for cancer mortality (multivariable-adjusted HR comparing extreme categories:
121 diagnostic circulating cotinine levels had a multivariable-adjusted HR for death of 1.76 (95% CI, 1.2
122  years before diagnosis, heavy smokers had a multivariable-adjusted HR for death of 2.47 (95% CI, 1.2
123                                  Results The multivariable-adjusted HR for death was 1.37 (95% CI, 1.
124  were confirmed by medical record review.The multivariable-adjusted HR for intermediate AMD comparing
125 al (5-yr survival: 48.6% vs 48.7%, P = 0.76; multivariable-adjusted HR for VATS approach: 1.08, 95% C
126 f 100 mg cholesterol/d was associated with a multivariable-adjusted HR of 0.90 (95% CI: 0.79, 1.02) f
127 dditional egg (55 g)/d was associated with a multivariable-adjusted HR of 1.17 (95% CI: 0.85, 1.61) i
128 stically significantly associated with risk (multivariable-adjusted HR per 1-g/d increment; 95% CI) o
129 ed with a lower risk of all-cause mortality [multivariable-adjusted HR: 0.87 (95% CI: 0.78, 0.97), P
130 [HR], 1.58; 95% CI, 1.34-1.87; P < .001) and multivariable-adjusted (HR, 1.48; 95% CI, 1.25-1.75; P <
131 R: 0.80 (95% CI: 0.70, 0.92), P = 0.002] and multivariable-adjusted [HR: 0.79 (95% CI: 0.68, 0.93), P
132 ion affected risk was also investigated, and multivariable adjusted HRs (95% CI) were 1, 0.88 (0.78,
133             In analysis of seasonal cycling, multivariable adjusted HRs (95% CI) were 1, 0.88 (0.83,
134                                              Multivariable adjusted HRs (95% confidence interval [CI]
135                                          The multivariable adjusted HRs for highest compared with low
136 intile of the inflammatory pattern score had multivariable adjusted HRs for premenopausal breast canc
137     Compared with no yogurt consumption, the multivariable-adjusted HRs (95% CIs) of mortality were 0
138                                       Pooled multivariable-adjusted HRs (95% CIs) were 0.93 (0.88, 0.
139                                              Multivariable-adjusted HRs (95% CIs) were 1.0 (reference
140                                          The multivariable-adjusted HRs (95% confidence intervals) fo
141           We used Cox regression to estimate multivariable-adjusted HRs and 95% CIs for total invasiv
142             Cox models were used to estimate multivariable-adjusted HRs between lifetime ovulatory cy
143           We used Cox regression to estimate multivariable-adjusted HRs for death according to nut co
144 ared with patients with insufficient levels, multivariable-adjusted HRs for death were 0.79 (95% CI,
145 icrovascular disease states versus none, the multivariable-adjusted HRs for the primary outcome were
146 n diet scores (highest quintile), the pooled multivariable-adjusted HRs for total mortality were 0.95
147                                       Pooled multivariable-adjusted HRs over increasing cumulative av
148 est egg intake quartile with the lowest, the multivariable-adjusted HRs were 0.81 for total stroke (9
149                                              Multivariable-adjusted HRs were 0.83 for fatty fish (95%
150          In comparison with 0.9 servings/wk, multivariable-adjusted HRs were 0.86 (95% CI: 0.76, 0.96
151 the greatest decrease (lowest quintile), the multivariable-adjusted HRs were 1.09 (95% CI, 1.04-1.15)
152 ersus below 0.34 x 10(9) cells per liter had multivariable-adjusted incidence rate ratios of 1.76 (95
153 ared with non-Hispanic whites, cardia cancer multivariable-adjusted incidence rate ratios were 35%-47
154  Cox proportional hazards models to estimate multivariable-adjusted incidence rate ratios.
155 d modeling procedures were used to calculate multivariable-adjusted incidence rates for major CVD eve
156                                              Multivariable adjusted linear mixed-effects models estim
157 spective weight change were analyzed using a multivariable-adjusted linear mixed-effects model.
158 ircumferential strain, and e' velocity using multivariable-adjusted linear mixed-effects models (to a
159  central obesity and cardiac mechanics using multivariable-adjusted linear mixed-effects models to ac
160                                      We used multivariable-adjusted linear regression models to asses
161                                     Separate multivariable-adjusted linear regression models were fit
162  with changes in LV geometry and function by multivariable-adjusted linear regression models.
163                                      We used multivariable-adjusted linear regressions to estimate me
164                                              Multivariable adjusted, linear regression within each co
165 rphism dosages with residuals generated from multivariable-adjusted logarithmically transformed BNP c
166 amivudine and emtricitabine were compared by multivariable adjusted logistic regression and Cox propo
167  migration and survival were evaluated using multivariable-adjusted logistic and Cox regression model
168 ticipants aged >/=18 y, 55% women), applying multivariable-adjusted logistic regression models to ass
169                                      We used multivariable-adjusted logistic regression models to exa
170                              In FHS, we used multivariable-adjusted logistic regression models to inv
171                                     Age- and multivariable-adjusted logistic regression models were u
172                                              Multivariable-adjusted logistic regression models were u
173                                           In multivariable-adjusted logistic regression models, each
174                                 According to multivariable-adjusted logistic regression models, telev
175         ORs and 95% CIs were estimated using multivariable-adjusted logistic regression models.
176                                              Multivariable-adjusted mean +/- SD changes in body weigh
177                                         In a multivariable adjusted model, DR was positively but nons
178             In the first subsample, the full multivariable-adjusted model showed that participants wi
179                                         In a multivariable-adjusted model, AF (n=1545) as a time-vary
180 n, although the latter was attenuated in the multivariable-adjusted model.
181 timates were substantially attenuated in the multivariable adjusted models for major cardiovascular d
182                                           In multivariable adjusted models HCV infection was associat
183                   Unadjusted and multilevel, multivariable adjusted models were used to measure the a
184                                           In multivariable adjusted models, bariatric surgery was ass
185                                       In the multivariable adjusted models, compared with nondrinkers
186                       In both unadjusted and multivariable adjusted models, higher plasma concentrati
187                                           In multivariable adjusted models, overall, blacks had 21% h
188 iation remained statistically significant in multivariable adjusted models.
189 01-2.09; IL6: HR, 1.55; 95% CI, 1.04-2.32 in multivariable adjusted models.
190 ighest compared with the lowest quartiles in multivariable adjusted models.
191 0.73; 95% CI: 0.62, 0.86; P-trend < 0.01) in multivariable adjusted models.
192  major disability or major disability in the multivariable-adjusted models (1.07 (0.89 to 1.29) and 0
193  baseline serum total and LDL cholesterol in multivariable-adjusted models (beta: 0.199, SE: 0.056, P
194 as associated with a 41% lower risk of HF in multivariable-adjusted models (hazard ratio: 0.59; 95% c
195  events were associated with incident CVD in multivariable-adjusted models (hazard ratio=1.61; 95% CI
196                                           In multivariable-adjusted models including age, sex, body m
197                                              Multivariable-adjusted models showed sex differences for
198 tissue volumes and with lower odds of FLD in multivariable-adjusted models without BMI.
199                                           In multivariable-adjusted models, 1-SD increases in eicosap
200                                           In multivariable-adjusted models, greater adherence to the
201                                           In multivariable-adjusted models, greater total sedentary t
202                                           In multivariable-adjusted models, living in the highest qui
203                                           In multivariable-adjusted models, nonsmoking, a healthy bod
204                                           In multivariable-adjusted models, sTie-2 and hepatocyte gro
205                                           In multivariable-adjusted models, the hazard ratio (95% con
206                                           In multivariable-adjusted models, we observed nonsignifican
207 onal hazards regression analysis in age- and multivariable-adjusted models.
208  site-specific cancer risk in unadjusted and multivariable-adjusted models.
209 natriuretic peptide) levels were examined in multivariable-adjusted models.
210 and circulating NP levels was assessed using multivariable-adjusted models.
211 mpared with individuals with normal BMI, the multivariable adjusted odds of CAC >0 were increased in
212                                The crude and multivariable adjusted odds of dying after cardiogenic s
213 ndence, and immunocompromised status (90-day multivariable adjusted odds ratio [OR], 1.56; 95% confid
214                                          The multivariable adjusted odds ratio for IgE levels greater
215 ge of time points with an MPP deficit > 20%, multivariable-adjusted odds of developing new significan
216 se in the time-weighted average MPP deficit, multivariable-adjusted odds of developing new significan
217 ed with those with 2+ high-risk factors, the multivariable-adjusted odds of having any disability in
218 s were associated with incident ACS, and the multivariable-adjusted odds ratio (95% confidence interv
219 th statistically and clinically significant (multivariable-adjusted odds ratio 12.5; 95% CI, 1.1-146.
220 seropositivity and the presence of fibroids (multivariable-adjusted odds ratio = 0.94, 95% confidence
221 lization risk was associated with older age (multivariable-adjusted odds ratio [OR] = 1.59 per 10 yea
222             In cross-sectional analyses, the multivariable-adjusted odds ratio for prevalent diabetes
223 ared with 17% (562/3335) without sibling MR (multivariable-adjusted odds ratio, 1.20; 95% confidence
224 al, 1.14-2.19) and obstructive lung disease (multivariable-adjusted odds ratio, 1.33; 95% confidence
225  higher among participants with restrictive (multivariable-adjusted odds ratio, 1.58; 95% confidence
226 rmalities visualized by computed tomography (multivariable-adjusted odds ratio, 2.67; 95% CI, 1.49-4.
227 gistic regression to estimate unadjusted and multivariable-adjusted odds ratios (ORs) and 95% confide
228 f breast cancer (for bilateral oophorectomy, multivariable-adjusted odds ratios = 0.60, 95% confidenc
229 0.77; for hysterectomy without oophorectomy, multivariable-adjusted odds ratios = 0.68, 95% confidenc
230  with the lowest quintile of DASH score, the multivariable-adjusted odds ratios for mid-frequency and
231 ntake with those in the lowest quintile, the multivariable-adjusted odds ratios of T2D were 2.13 [95%
232 endence and immunocompromised status (90-day multivariable adjusted OR 1.56 (95% CI 1.04-2.35)).
233  with pneumonias caused by S. aureus (90-day multivariable adjusted OR 3.69 (1.73-7.90).
234 nias caused by Staphylococcus aureus (90-day multivariable adjusted OR, 3.69; 95% CI, 1.73-7.90).
235                                Moreover, the multivariable-adjusted OR for short telomeres (z score <
236 cer risk and those in the top quintile had a multivariable-adjusted OR of 3.02 [95% confidence interv
237                                          The multivariable-adjusted ORs of hyperglycemia associated w
238                                          The multivariable-adjusted ORs of hyperglycemia based on dif
239                                          The multivariable-adjusted ORs of obesity based on different
240  72.3 in women and from 94.2 to 81.3 in men (multivariable-adjusted P interaction by sex <0.001).
241 n (apical view), and longitudinal synchrony (multivariable-adjusted P<0.0001).
242                                              Multivariable adjusted Poisson models were used to estim
243                                              Multivariable-adjusted Poisson regression was used to id
244                                           In multivariable-adjusted pooled analyses, higher proportio
245 ss than five servings per week of fruit, the multivariable-adjusted PR of diverticulosis was 0.60 (95
246 hose aged 75 years or older (37.3% vs 36.7%; multivariable-adjusted prevalence ratio, 0.81 [95% CI, 0
247  White adults (41.5% vs 48.2%, respectively; multivariable-adjusted prevalence ratio, 0.88; 95% CI, 0
248 e aged 45 years to 64 years (49.7% vs 36.7%; multivariable-adjusted prevalence ratio, 1.18 [95% CI, 1
249 mong those without health insurance (24.2%) (multivariable-adjusted prevalence ratio, 1.40 [95% CI, 1
250 care facility (48.4% vs 26.5%, respectively; multivariable-adjusted prevalence ratio, 1.48 [95% CI, 1
251  care visit in the past year (49.1% vs 8.0%; multivariable-adjusted prevalence ratio, 5.23 [95% CI, 2
252  lowest (<5%) predicted ASCVD risk category, multivariable-adjusted prevalence ratios (95% confidence
253                                              Multivariable-adjusted proportional hazard models adjust
254                                              Multivariable-adjusted proportional hazards models revea
255 an five servings of vegetables per week, the multivariable-adjusted PRs of diverticulosis were 0.84 (
256 djusted rate ratio, 1.53 [CI, 1.04 to 2.25]; multivariable-adjusted rate difference, 1.5 [CI, -0.1 to
257 ted rate ratio, 1.62 [95% CI, 1.07 to 2.45]; multivariable-adjusted rate difference, 1.7 [CI, -0.1 to
258 nks per week was associated with a 19% lower multivariable-adjusted rate of HF compared with never dr
259 was shown between vitamin C and HNC overall (multivariable-adjusted rate ratio for quartile 4 compare
260 ; 95% CI: 0.23, 0.66; P-trend < 0.001), OCC (multivariable-adjusted rate ratio for quartile 4 compare
261 % CI: 0.16, 0.77; P-trend < 0.05), and OHPC (multivariable-adjusted rate ratio for quartile 4 compare
262 ke from supplements (>=1000 mg/d vs. no use: multivariable-adjusted rate ratio, 1.53 [CI, 1.04 to 2.2
263 t or below the Tolerable Upper Intake Level: multivariable-adjusted rate ratio, 1.62 [95% CI, 1.07 to
264                                 In 2017, the multivariable-adjusted rate ratios comparing women with
265                            Outcomes included multivariable-adjusted rates of myocardial infarction, s
266 ted to the explanation of circulating PLP in multivariable-adjusted regression models.
267                                 We performed multivariable-adjusted regressions and 2-sample Mendelia
268 olor (for black hair vs. red or blonde hair, multivariable-adjusted relative risk (RR) = 0.99, 95% co
269 d adults with and without AKI and reported a multivariable-adjusted relative risk (RR) for the associ
270  (for >6 years of use compared with <1 year, multivariable-adjusted relative risk = 1.01, 95% confide
271  (for >6 years of use compared with <1 year, multivariable-adjusted relative risk = 1.09, 95% confide
272  (for >6 years of use compared with <1 year, multivariable-adjusted relative risk = 1.10, 95% confide
273 sociated with a higher risk of colon cancer (multivariable-adjusted relative risk = 1.54, 95% confide
274                                              Multivariable-adjusted repeated measure logistic regress
275             Associations were examined using multivariable-adjusted restricted cubic splines based on
276 s not on statin therapy pre-hospitalization, multivariable adjusted risk ratios for filling a high-in
277  15 years of follow-up in the Bruneck Study, multivariable adjusted risk ratios per one-SD higher log
278 nts had a 2.12-, 2.06-, and 2.13-fold higher multivariable-adjusted risk of incident CKD, composite o
279  48%; P-trend = 0.02 across quartiles) lower multivariable-adjusted risk of incident dementia.
280 o 9 h/night, short sleepers had a 20% higher multivariable-adjusted risk of incident MI (HR: 1.20; 95
281                           Vehicle ownership (multivariable-adjusted risk ratio [aRR], 1.58) increased
282 ival to discharge in multivariable analysis (multivariable-adjusted risk ratio [RR] per minute delay,
283                                              Multivariable-adjusted risks were elevated only in men w
284 in tanning ability (for dark tan vs. no tan, multivariable-adjusted RR = 0.98, 95% CI: 0.92, 1.05), s
285 rick skin phototype (for type IV vs. type I, multivariable-adjusted RR = 0.99, 95% CI: 0.92, 1.05).
286 n with blisters vs. practically no reaction, multivariable-adjusted RR = 1.01, 95% CI: 0.93, 1.08), o
287                                          The multivariable-adjusted RR of having >/=4 cups (600 mL) c
288  women in the lowest quintile of intake, the multivariable-adjusted RR of hearing loss among women in
289 urvival with favorable neurological outcome (multivariable-adjusted RR per minute delay, 0.95 [95% CI
290 also associated with decreased risk of ROSC (multivariable-adjusted RR per minute delay, 0.97 [95% CI
291 9]), decreased risk of survival at 24 hours (multivariable-adjusted RR per minute delay, 0.97 [95% CI
292 scharge (21.0% [49/233] vs 33.1% [438/1325]; multivariable-adjusted RR, 0.75 [95% CI, 0.60-0.93]; P =
293                                       Pooled multivariable adjusted RRs (95% CIs) comparing the highe
294                                              Multivariable-adjusted RRs were pooled using random-effe
295                                              Multivariable adjusted standardized 1-year mortality was
296 with a functioning graft, the unadjusted and multivariable adjusted subdistribution HRs in 2014 versu
297                                              Multivariable-adjusted subgroup analysis by QRS duration
298 nterval) interval scale traits and conducted multivariable-adjusted, trait-specific univariate genome
299 ong 718 480 patients studied, unadjusted and multivariable-adjusted transplant rates differed conside
300                                              Multivariable adjusted TSH, FT4 and T3 levels were 25%,

 
Page Top